AAAAAA

   
Results: 1-9 |
Results: 9
Inhibition of LPS-induced airway hyperresponsiveness and airway inflammation by LPS antagonists
Authors: Schwartz, DA Christ, WJ Kleeberger, SR Wohlford-Lenane, CL
Citation: Da. Schwartz et al., Inhibition of LPS-induced airway hyperresponsiveness and airway inflammation by LPS antagonists, AM J P-LUNG, 280(4), 2001, pp. L771-L778
Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531
Authors: Yang, H Daun, JM Rose, JR Christ, WJ Gusovsky, F Chow, JC
Citation: H. Yang et al., Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531, J ENDOTOX R, 6(6), 2000, pp. 447-452
Structure-activity relationships of halichondrin B analogues: Modifications at C.30-C.38
Authors: Wang, Y Habgood, GJ Christ, WJ Kishi, Y Littlefield, BA Yu, MJ
Citation: Y. Wang et al., Structure-activity relationships of halichondrin B analogues: Modifications at C.30-C.38, BIOORG MED, 10(10), 2000, pp. 1029-1032
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins
Authors: Rose, JR Mullarkey, MA Christ, WJ Hawkins, LD Lynn, M Kishi, Y Wasan, KM Peteherych, K Rossignol, DP
Citation: Jr. Rose et al., Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins, ANTIM AG CH, 44(3), 2000, pp. 504-510
Selective formation of C-2 azidodeoxy-D-glucose derivatives from D-glucal precursors using the azidonitration reaction
Authors: Seeberger, PH Roehrig, S Schell, P Wang, Y Christ, WJ
Citation: Ph. Seeberger et al., Selective formation of C-2 azidodeoxy-D-glucose derivatives from D-glucal precursors using the azidonitration reaction, CARBOHY RES, 328(1), 2000, pp. 61-69
Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasmafrom human subjects with various lipid levels
Authors: Wasan, KM Strobel, FW Parrott, SC Lynn, M Christ, WJ Hawkins, LD Rossignol, DP
Citation: Km. Wasan et al., Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasmafrom human subjects with various lipid levels, ANTIM AG CH, 43(10), 1999, pp. 2562-2564
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
Authors: Chow, JC Young, DW Golenbock, DT Christ, WJ Gusovsky, F
Citation: Jc. Chow et al., Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction, J BIOL CHEM, 274(16), 1999, pp. 10689-10692
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide
Authors: Kawata, T Bristol, JR Rossignol, DP Rose, JR Kobayashi, S Yokohama, H Ishibashi, A Christ, WJ Katayama, K Yamatsu, I Kishi, Y
Citation: T. Kawata et al., E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide, BR J PHARM, 127(4), 1999, pp. 853-862
Synthetic endotoxin antagonists
Authors: Rossignol, DP Hawkins, LD Christ, WJ Kobayashi, S Kawata, T Lynn, M Yamatsu, I Kishi, Y
Citation: Dp. Rossignol et al., Synthetic endotoxin antagonists, ENDOTOXIN IN HEALTH AND DISEASE, 1999, pp. 699-717
Risultati: 1-9 |